Found 1,258 investors
Gruender Motor
United States
Dr. Richard Klausner is a Co-Founder and serves as the Chairman at LifeMine. He is a Co-Founder and serves as Chief Scientist & Chairman at Atlos Labs. He is the Founder and serves as the Executive Chairman & Board Member at Lyell. He is a Co-Founder and serves as the Executive Chairman at Mindstrong. He serves as Chairman at Sonoma Biotherapeutics. He serves as Board Member and Advisor at Orca Bio. Previously, he served as Chief Executive Officer and Board Member at Lyell. Dr. Richard Klausner is a Co-Founder & serves as Board Member at Juno Therapeutics. He served as the Chief Medical Officer & Senior Vice President at Illumina. He is a Scientific Advisor at Aragon Pharmaceuticals. He serves as a Board Member and Scientific Advisor at Grail (Biotechnology). He is the former Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was a Board Member at Audax. He was the eleventh director of the National Cancer Institute between 1995 and 2001. His research has been recognized with awards including the Outstanding Investigator Award from the American Federation of Clinical Research and the William Damashek Prize for major discoveries in hematology. He received the 1997-1998 Dickson Prize in Medicine and the 1998 Raymond Bourgine Award. He has served as an Advisor to the Presidents of the Academies for Counter-terrorism and Liaison to the White House Office of Science & Technology Policy. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner is a past president of the American Society of Clinical Investigation and has been Chairman of the National Science Education Standards Projects of the National Academy of Sciences. He previously served as the Chief Medical Officer and Senior Vice President at The Column Group. Dr. Klausner currently chairs the International Advisory Board for Samsung, is the Chairman of Audax Health, and previously chaired the Strategic Oversight Council of Sanofi. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner holds an M.D. from Duke Medical School. He serves as Chairman at Xtremity.
Individual/Angel
Grünwald Equity Management
Germany
Founded in 2001, Grünwald Equity Management is a private equity firm based in Grünwald, Germany. The firm prefers to invest in medium-sized companies across all sectors in the manufacturing, retail and services industries. Additionally, the firm invests in the origination and development of geothermal energy power plants located in Germany. The firm does not invest in biotech, complex software development, real estate, and commodity exploration sectors as well as highly regulated industries.
Private Equity Firm
Grupo de Negocios Duero
Spain
Grupo de Negocios Duero is a corporation with business activities related to other independent services. It also specializes in late venture, middle market, mature and turnaround transactions. The firm was founded in 1998 and is based in Madrid, Spain.
Strategic Acquirer
Gustaf Ramel
United States
Dr. Cameron Marlow is a Co-Founder and serves as Chief Technology Officer at Apella. He was a Co-Founder and served as the Chief Technology Officer at Physera. He is also an Angel Investor. Prior to Physera, Cameron founded and led the Data Science team at Facebook for six years, and was responsible for multiple applied science, product optimization, and other data-driven engineering teams. Prior to Facebook, Cameron studied social networks at Yahoo! Research and the MIT Media Lab, and his work has been published in Nature and Proceedings of the National Academy of Science (PNAS). He has also advised Buzzfeed, Etsy, and other startups on data applications and engineering management. Cameron holds a B.S. in Computer Science from the University of Chicago and a Ph.D. in Media Arts and Sciences from MIT.
Individual/Angel
Gustavo Caetano
United States
Dr. Steven Wheelwright is an Angel Investor. He serves as Senior Advisor at NaviMed Capital. He also serves as Advisory Board Member at CareSyntax. He also served as Limited Partner at Cornerstone Continuity Partners. He is the Advisor Emeritus and former President of Brigham Young University, Hawaii a part of the Church Education System of the Church of Jesus Christ of Latter-day Saints. He is also former Professor and Senior Associate Dean at Harvard Business School. From 2003-2006, he was a Baker Foundation Professor and Senior Associate Dean, Director of HBS Publication Activities. In that role, he oversaw the HBS Publishing Company (including HBR, HBS Press books, HBS cases, e-Learning products, and newsletters/conferences). He also oversaw the major on-campus construction projects. From 2000-2003, he and his wife fulfilled a full-time voluntary assignment as the President of the London, England Mission for the Church of Jesus Christ of Latter-day Saints. From 1995-1999, he served as Senior Associate Dean responsible for the MBA Program at Harvard. He then served as Senior Associate Dean and Director of Faculty Hiring and Planning and had oversight responsibility for distance learning. Professor Wheelwright first taught at Harvard from 1971-1979 and was the Thomas Henry Carroll-Ford Foundation Visiting Professor from 1985-1986. He rejoined the Harvard faculty in 1988. In his years away from Harvard, he was the Kleiner, Perkins, Caufield and Byers Professor of Management at Stanford University Graduate School of Business. His most recent book, developed with HBS colleague Clayton Christensen and Stanford colleague, Robert Burgelman, is Strategic Management of Technology and Innovation, 4th ed. Dr. Wheelwright is also the author or co-author of more than a dozen other books. He has a B.S. degree in Mathematics from the University of Utah and an M.B.A. and Ph.D. from Stanford University's Graduate School of Business. In addition to his Harvard and Stanford positions, he served on the faculty of INSEAD (European Institute of Management) in Fontainebleau, France. He has consulted in the areas of business and operations strategy and improving product development capabilities. He currently serves as a Board member at O.C. Tanner Company (service awards), at Zions Bank (banking), and at the Polynesian Cultural Center (cultural attraction and entertainment venue adjacent to BYU-Hawaii campus). He also serves as a Senior Advisor Emeritus at Surgical Intelligence
Individual/Angel
Guy Fleury
United States
Mr. Brian Zotter is a Co-Founder & serves as Chief Technology Officer at Cacheflow. Mr. Brian Zotter co-founded and served as the Chief Technology Officer at YesPath. He is an Angel Investor. Mr. Zotter served as Vice President, Technology & Product at ClearStory Data. He has over 15 years of engineering and product management experience building and delivering enterprise-class products. Most recently, Brian was Vice President of Engineering at Salesforce.com. Prior to Salesforce, Brian held senior engineering positions at EMC, BEA Systems and MobiTV. He is also a two-time founder and entrepreneur having founded Connectize and Boxcar Software (acquired by Documentum). With 8 patents in PaaS, SaaS and multiple other fields, he's passionate about building and leading innovative, high-performance engineering teams. He holds a Degree in Physics - Computer Science from Stony Brook University (SUNY) and a BS in Computer Science from Dowling College.
Individual/Angel
Guy Vanhauteghem
Japan
Mr. Takeo Matsuda serves as Managing Director (Corporate Governance) at Reapra. He serves as Executive Advisor & Board Member at Stargral. He served as Chief Financial Officer & Board Member at Foodison. He also served as Board Member at Spout Entertainment Group. Takeo joined Reapra in January 2015. Prior to Reapra, he was a successful CFO in Japan for a total of 7 years. He held the position at Groupon Japan (acquired by Groupon Inc, Nasdaq GRPN) and Enigmo (3665, TSE Mothers). Previously he has been an investment banker at Lehman Brothers, specializing in the TMT sector, and an auditor at Deloitte. Since 2013, Takeo has personally supported more than 10 IT start-ups in Asia as a seed investor. Takeo holds an MBA from the University of Texas, Austin and a B.A. in Economics from Keio University, Japan. He has served as a Director at Coent Venture Partners.
Individual/Angel
Gyeongnam Venture Investment
South Korea
Founded in 2019, Gyeongnam venture investment is a venture capital investment firm based in Gyeongsangnam-Do, South Korea. The firm prefers to invest in the internet, communication, IoT, electricity, electronics, semiconductors, materials, automobiles, healthcare, biotechnology, cultural contents such as movies, performances, musicals and other industries with growth potential sectors.
Venture Capital
Halmek Ventures
Japan
Founded in 2014, Halmek Ventures is a corporate venture arm of Harumek Holdings Company based in Tokyo, Japan. The firm seeks to invest in companies focused on health check products, health solutions, and other new businesses that contribute to the economic and social development of Japan and the World.
Venture Capital
Han Capital Management
San Francisco, California, United States
HAN Capital is a private equity firm investing in real estate ,focussed in health care, self storage and other value add opportunities.
Private Equity Firm
Hangzhou Anysoft Information Technology Company
China
Hangzhou Anysoft Information Technology Co Ltd is mainly engaged in the design and development of mobile reading platforms. The company is organized into three business divisions: mobile reading service, information business, and other value-added telecommunications services. Its mobile reading service division provides a full range of reading services through its own reading platform, third-party platform and telecom operators' reading platform; information business division provides users with professional magazines and industries through mobile newspapers and self-media push; other value-added telecommunications services mainly includes music, video, games, animation and other content.
Venture Capital
Hanhai BioLabs
United States
Hanhai BioLabs is a startup acceleration firm based in Burlingame, California. The firm provides seed funding, mentoring services, office spaces, and other necessary resources for life science startups.
Accelerator
Incubator
Harbor Capital Advisors, Inc.
Il Chiaro, Emilia-Romagna, Italy
Harbor Capital Advisors provides its services to investment companies, pooled investment vehicles, and corporations and other businesses.
Finance
Financial Services
Venture Capital
Venture Capital
Harry Hyman
United States
Dr. Una Ryan served as Managing Director at Golden Seeds. She is a Board Member of Cortexyme .She is currently Research Professor of Medicine at BU School of Medicine and serves on its Board of Visitors. Her board positions include AMRI (Lead Director, Nominating and Compensation committees) and MSH (Audit and Compensation committees). She was most recently President and CEO of Diagnostics For All (DFA), a non-profit organization developing inexpensive diagnostics for global health and agricultural uses. Previously, she was President and CEO of AVANT Immunotherapeutics, Inc, (NASDAQ) a company developing vaccines and immunotherapeutics for cancer, travellers, food safety and global health and also a member of its Board of Directors. Prior to AVANT, she was director of Health Sciences at Monsanto Company. Before that, she held a number of positions in academia, including Research Professor of Surgery at Washington University School of Medicine in St. Louis and Professor of Medicine at the University of Miami School of Medicine. She was also Chair of the Massachusetts Biotechnology Council, served on its Board, as well as the Biotechnology Industry Organization, New England Healthcare Institute, Board of Associates of the Whitehead Institute, Strategy and Policy Council of the MIT Center for Biomedical Innovation, Massachusetts Life Sciences Collaborative Leadership Council and the Goddard Council on science, technology, engineering and mathematics education. She holds a PhD in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology, Microbiology and Chemistry from Bristol University. She received an Honorary Doctor of Science degree from Bristol University in 2009. In 2007, she received the Albert Einstein Award for outstanding achievement in the life sciences. In 2002 Her Majesty Queen Elizabeth II awarded she the Order of the British Empire (OBE) for services to research, development and promotion of biotechnology. She is also an Angel Investor. She also served as a Board Member at EMulate Therapeutics.
Individual/Angel
Harvey Spevak
United States
Mr. Wilco Jiskoot serves as Industrial Adviser at CVC Capital Partners. He serves as a Strategic Advisor at Ramphastos Investments. Presently, he is a member of numerous supervisory and advisory boards in the Netherlands (among others: Constellation Netherlands Holdings BV, Ijsvogel NV, Oyens & Van Eeghen, Jumbo NV). He holds an MBA from Erasmus University, Rotterdam. He served as Chairman at Eyeworks. Presently, he is a member of numerous supervisory and advisory boards in the Netherlands (among others: Constellation Netherlands Holdings BV, Ijsvogel NV, Oyens & Van Eeghen, Jumbo NV).Drs Jiskoot holds an MBA from Erasmus University, Rotterdam.
Individual/Angel
Hatch Biofund Management
United States
Hatch Biofund Management is a venture capital firm based in Doylestown, Pennsylvania. The Hatch Biofund is a companion fund to the incubators owned or managed by the Pennsylvania Biotechnology Center. The firm provides both seed-stage and Series A funding to promising companies from its new BioAccelerator and the PABC incubator, as well as other opportunities.
Venture Capital
HaxVentures
Russian Federation
Founded in 2015, HaxVentures is a venture capital fund based in Moscow, Russia. The firm specializes in seed investments. The firm seeks to invest in projects related to wearable devices, 3D printing, the internet, and other things.
Venture Capital
HBM Partners
Zug, Zug, Switzerland
HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies.
Biotechnology
Financial Services
Life Science
Venture Capital
Venture Capital
Healthcare Partners Investments
United States
Founded in 2004, Healthcare Partners Investments is an investment firm based in Oklahoma City, Oklahoma. The firm owns and operates hospitals, multiple outpatient therapy, imaging centers and other medical practices.
Venture Capital
Health Resources and Services Administration
Rockville, Maryland, United States
HRSA provides tens of millions of Americans access to affordable health care and other help.
Association
Government
Health Care
Office Administration
Government Office
Showing 561 to
580 of
1,258 results